О. В. Головенко
Russian Medical Academy of Continuous Professional Education · 29 works · 494 citations · h-index 7
Top works
- Oral p38 Mitogen-Activated Protein Kinase Inhibition With BIRB 796 for Active Crohn’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- Social and demographic characteristics, features of disease course and treatment options of inflammatory bowel disease in Russia: results of two multicenter studies
- PROJECT: CLINICAL GUIDELINES FOR THE DIAGNOSTICS AND TREATMENT OF ULCERATIVE COLITIS
- Clinical guidelines. Crohn’s disease (К50), adults
- Ulcerative colitis (K51), adults
- Diagnosis and treatment of the irritable bowel syndrome: clinical guidelines of the Russian gastroenterological association and Russian association of coloproctology
- Interactions between symptoms and motor and visceral sensory responses of irritable bowel syndrome patients to spasmolytics (antispasmodics).
- Long-term results of medical treatment in patients with a severe attack of ulcerative colitis
- Modern principles of conservative treatment of mild and moderate forms of ulcerative colitis
- [Activity indices--objective criteria of the estimation of severity level of ulcerous colitis].
- Consensus on controversial issues of the surgery for Crohn’s disease by Delphi method
- Опыт лечения рака толстой кишки у пациентов с язвенным колитом в ГНЦ колопроктологии
- Роль рифаксимина в коррекции СРК-подобной симптоматики у пациентов с воспалительными заболеваниями кишечника
- [Role of rifaximin in correction of IBS-like symptoms in patients with inflammatory bowel disease].
- ОПЫТ УСПЕШНОЙ ТРАНСПЛАНТАЦИИ ФЕКАЛЬНОЙ МИКРОБИОТЫ ПРИ РЕЦИДИВИРУЮЩЕЙ ИНФЕКЦИИ CLOSTRIDIUM DIFFICILE
- The choice of treatment approach for mild and moderate ulcerative colitis: a review
- [The efficacy of gastrotsepin in functional diseases of the large intestine].
- Терминальный илеит: вопросы дифференциального диагноза и перспективы лечения
- Резистентность к внутривенной терапии глюкокортикостероидами при язвенном колите: нерешенные вопросы (обзор литературы)
- Vedolizumab in the treatment of inflammatory bowel diseases: whom and how?